Last reviewed · How we verify

NCT03660904

A Comparison Between Home-made Vitrification & Thawing Media and a Commercially Available Brand on Blastocyst

Completed Phase 2, PHASE3 Last updated 7 September 2018
What this trial tests

Phase 2, PHASE3 trial testing home made vitrification & thawing kit in Blastocyst Disintegration in 74 participants. Completed in 15 June 2018.

Timeline
1 October 2015
Primary endpoint
1 October 2017
15 June 2018

Quick facts

Lead sponsorBenha University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment74
Start date1 October 2015
Primary completion1 October 2017
Estimated completion15 June 2018

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 22 to 37, female only, with Blastocyst Disintegration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate and compare cryo-survival, re-expansion, and implantation rates of Day 5/6 human blastocysts that were vitrified with home-made media (HM) according to (Shady grove protocol) and warmed with gradual Thawing HM according to (Kuwayama protocol)with Global Fast Freeze/Thaw Kits (LifeGlobal, Canada).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing